
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of
23rd February 2022
Valereum Plc
("Valereum" or the "Company")
Valereum exercises option to move to 90% of Gibraltar Stock Exchange
(Final transfer is subject only to Gibraltar Financial Services Commission approval)
Valereum, the
Additionally, both Valereum and the GSEG have also executed the first stage of the revised agreement, whereby Valereum has now paid the GSEG a total of
The remaining option over 40% of the shares in GSX will be exercised in due course, with the final transfer and registration of all transfers in the shares in the GSX to reach the agreed final 90% ownership, being subject to GFSC approval and any shareholder approval required by AQUIS.
The GSX is a regulated exchange market which also holds an Multi-Lateral Trading Facility ("MTF") licence for the listing of specific forms of security under the European Markets in Financial Instruments Directive ("MiFID").
Richard Poulden, Chairman of Valereum commented: "This is a very significant step forward for Valereum towards taking control of the Gibraltar Stock Exchange. Valereum directors are working closely with the GSX to plan for its future path.
The Directors of the Company accept responsibility for the contents of this announcement.
END
Enquiries:
Valereum Plc
Richard Poulden, Chairman
Tel: +971 4584 6284
AQSE Corporate Adviser
Peterhouse Capital Limited
Tel: +44 (0) 207 469 0930
Investor Relations
J&H Communications Limited
James Henderson
Tel: +44 (0)7774 444163
james@j-hcommunications.com
George Hudson
Tel: +44 (0)7803 603130
george@j-hcommunications.com
For more information, please visit the Company's website at www.valereum.gi
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.